A5042570000- Antiplatelet Therapy and Cardiovascular Diseases
- Atrial Fibrillation Management and Outcomes
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Coronary Interventions and Diagnostics
- Acute Ischemic Stroke Management
- Meta-analysis and systematic reviews
- Cardiac Imaging and Diagnostics
- Lipoproteins and Cardiovascular Health
- Academic Writing and Publishing
- Acute Myocardial Infarction Research
- Down syndrome and intellectual disability research
- Cardiac Arrhythmias and Treatments
- Nuclear Receptors and Signaling
- Cardiomyopathy and Myosin Studies
- Autism Spectrum Disorder Research
- Attention Deficit Hyperactivity Disorder
- Venous Thromboembolism Diagnosis and Management
- Apelin-related biomedical research
- Mast cells and histamine
- Vitamin K Research Studies
- Atherosclerosis and Cardiovascular Diseases
- Central Venous Catheters and Hemodialysis
- scientometrics and bibliometrics research
- Computational Drug Discovery Methods
- Cardiovascular Issues in Pregnancy
University of Catania
2023-2025
Policlinico Universitario di Catania
2023-2025
A. O. Ordine Mauriziano di Torino
2022
The evolution of anticoagulation therapy, from vitamin K antagonists to the advent direct oral anticoagulants (DOACs) almost two decades ago, marks significant progress. Despite improved safety demonstrated in pivotal trials and post-marketing observations, persistent concerns exist, particularly regarding bleeding risk absence therapeutic indications specific subgroups or clinical contexts. Factor XI (FXI) has recently emerged as a contributor intraluminal thrombus formation growth, playing...
Single antiplatelet therapy (SAPT) and intensified antithrombotic regimens (prolonged dual [DAPT] or pathway inhibition [DPI]) are recommended for secondary prevention in patients who underwent percutaneous coronary intervention (PCI) after initial DAPT. We aimed to characterize eligibility such strategies explore what extent guidelines applied clinical practice. Patients PCI acute chronic syndrome completed DAPT were analyzed from a prospective registry. categorized into SAPT, prolonged...
Background – Although Factor XI (FXI) inhibitors are currently tested for the prevention of thrombotic events, their early treatment could prevent thrombus consolidation in ST-segment elevation myocardial infarction (STEMI). This study aims to characterize coagulation FXI levels and variations patients with STEMI undergoing primary percutaneous coronary intervention (PCI). Methods Patients were prospectively enrolled between December 2023 May 2024. activity (FXIa) measured at admission after...
Randomized trials are often presented at medical conferences and published simultaneously or later. Predictors of simultaneous publication its consequences undetermined. Our aim was to characterize the practice publication, identify predictors, evaluate impact.
Aim: This paper describes the steps of a protocol for developing and assessing non-pharmacological intervention, specifically Serious Game, with goal improving eight cognitive skills in adults Intellectual Disabilities. games that focus on one deficit and/or are restricted to disorder have been developed improve people There is lack single tool targets various as well broader spectrum disorders. Purpose: The presentation which new Game will be evaluated randomised control trial intervention....
Introduction and objectives: Randomized trials are often presented at medical conferences published simultaneously or later. Predictors of simultaneous publication its consequences undetermined. Our aim was to characterize the practice publication, identify predictors, evaluate impact. Methods: In this cross-sectional study, we included randomized late-breaking science sessions major cardiovascular from 2015 2021. The association trial characteristics with timing analyzed. impact vs...